In MS, one hypothesis is that insufficient peripheral IDO activity—supported by evidence of reduced IDO mRNA expression in the blood of MS patients—may fail to suppress autoreactive T cells, thereby facilitating autoimmune attacks. Here, IDO1 is linked to myeloid sarcoma.